← Leaderboards
Su-Young Kim
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingTumorOsteosarcomaUnited States National Institutes Of HealthUnited StatesChildhoodGenesNeoplasm MetastasisOperative Surgical ProceduresBiologicalClinical TrialsCell LineInhibitor/AntagonistChemotherapyLaboratoriesMutationSurvival RateMemberPreparationResearch StudyEvaluationCollaborationsGeneticMalignant Bone Neoplasm
Grant awards (16)
The NIH Pediatric and wildtype GIST Clinic$33,753
ZIA · FY2012 · CA · contact PI
Clinical Trial of AZD0530 in Recurrent Osteosarcoma$11,251
ZIA · FY2012 · CA · contact PI
Sequencing the Osteosarcoma Kinome$5,625
ZIA · FY2012 · CA · contact PI
Modeling the MET Oncogene in Osteosarcoma$5,625
ZIA · FY2012 · CA · contact PI
The NIH Pediatric and wildtype GIST Clinic$206,206
ZIA · FY2011 · CA · contact PI
Clinical Trial of AZD0530 in Recurrent Osteosarcoma$68,735
ZIA · FY2011 · CA · contact PI
Modeling the MET Oncogene in Osteosarcoma$34,368
ZIA · FY2011 · CA · contact PI
Sequencing the Osteosarcoma Kinome$34,368
ZIA · FY2011 · CA · contact PI
The NIH Pediatric and wildtype GIST Clinic$178,027
ZIA · FY2010 · CA · contact PI
Modeling the MET Oncogene in Osteosarcoma$106,816
ZIA · FY2010 · CA · contact PI
Clinical Trial of AZD0530 in Recurrent Osteosarcoma$35,605
ZIA · FY2010 · CA · contact PI
Sequencing the Osteosarcoma Kinome$35,605
ZIA · FY2010 · CA · contact PI
Sequencing the Osteosarcoma Kinome$66,552
ZIA · FY2009 · CA · contact PI
The NIH Pediatric and wildtype GIST Clinic$66,552
ZIA · FY2009 · CA · contact PI
Modeling the MET Oncogene in Osteosarcoma$66,552
ZIA · FY2009 · CA · contact PI
Clinical Trial of AZD0530 in Recurrent Osteosarcoma$22,183
ZIA · FY2009 · CA · contact PI